• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Diabetes: Dexcom wins European approval for continuous glucose monitor | Regulatory Roundup

Diabetes: Dexcom wins European approval for continuous glucose monitor | Regulatory Roundup

June 14, 2012 By MassDevice staff

MassDevice.com Regulatory Roundup

 Dexcom wins European approval for next-gen continuous glucose monitor
San Diego, Calif.-based Dexcom Inc. (NSDQ:DXCM) won CE Mark approval for its latest generation continuous glucose monitor, the Dexcom G4.

The device touts improved performance and reliability, according to CEO Terrance Gregg, and the company is working to establish a commercial launch plan for the coming months.

Dexcom specializes in continuous blood glucose measurement tools, with wearable devices for patients as well as tools designed for hospital use, according to a press release.

The device maker recently announced a partnership with the Juvenile Diabetes Research Foundation, aimed at developing a wireless transmission system to send data from a continuous glucose monitor to an "artificial pancreas" which would respond to highs and lows in blood sugar by automatically adjusting the flow of an insulin pump.

DXCM shares were up 2.6% to $12.41 as of about 5:00 p.m. today.
Read more

 Abiomed lands Canadian approval for Impella cVAD heart pump
Abiomed (NSDQ:ABMD) continued its global march with Canadian approval for its Impella catheter-based heart pump used to provide support for patients with heart conditions.

Regulators approved the device for up to 5 days of use in cardiology and cardiac surgery as a circulatory support system for patients with reduced pumping ability.

The Impella cVAD device noted 1st-in-man use in April and won CE Mark approval in the European Union just weeks later. The device has yet to win clearance in the U.S.

ABMD shares were up 2.2% to $21.42 as of about 5:00 p.m. today.
Read more

 FDA approves world’s thinnest full-length cochlear electrode
Cochlear Americas won FDA approval for newest electrode for use in implantable hearing solutions, the Slim Straight. The device is designed to preserve delicate cochlear structures as its inserted into the inner ear.  
Read more

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: Abiomed, Cochlear Americas, Dexcom, Hearing

More recent news

  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy